Hims & Hers Health, Inc. (NYSE:HIMS) Insider Michael Chi Sells 7,259 Shares

Hims & Hers Health, Inc. (NYSE:HIMS) insider Michael Chi sold 7,259 shares of Hims & Hers Health stock in a transaction that occurred on Monday, February 10th. The stock was sold at an average price of $43.28, for a total value of $314,169.52. Following the transaction, the insider now owns 193,601 shares of the company’s stock, valued at $8,379,051.28. This represents a 3.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Michael Chi also recently made the following trade(s):

• On Friday, January 24th, Michael Chi sold 17,304 shares of Hims & Hers Health stock. The shares were sold at an average price of $31.00, for a total value of $536,424.00.
• On Friday, January 10th, Michael Chi sold 7,259 shares of Hims & Hers Health stock. The shares were sold at an average price of $24.07, for a total value of $174,724.13.
• On Tuesday, December 24th, Michael Chi sold 17,303 shares of Hims & Hers Health stock. The shares were sold at an average price of $27.97, for a total value of $483,964.91.
• On Thursday, December 19th, Michael Chi sold 7,500 shares of Hims & Hers Health stock. The shares were sold at an average price of $26.00, for a total value of $195,000.00.
• On Tuesday, December 10th, Michael Chi sold 7,259 shares of Hims & Hers Health stock. The shares were sold at an average price of $32.25, for a total value of $234,102.75.
• On Monday, December 2nd, Michael Chi sold 2,054 shares of Hims & Hers Health stock. The shares were sold at an average price of $33.56, for a total value of $68,932.24.

Hims & Hers Health Stock Performance

Shares of HIMS traded down $1.21 during trading hours on Tuesday, reaching $43.56. The stock had a trading volume of 7,309,816 shares, compared to its average volume of 11,847,643. Hims & Hers Health, Inc. has a 12 month low of $9.14 and a 12 month high of $46.01. The stock has a market capitalization of $9.52 billion, a PE ratio of 99.01 and a beta of 1.35. The company’s 50-day moving average is $30.50 and its two-hundred day moving average is $23.43.

Analyst Ratings Changes

Several equities analysts have weighed in on HIMS shares. Citigroup cut Hims & Hers Health from a “neutral” rating to a “sell” rating and lifted their price objective for the company from $24.00 to $25.00 in a report on Friday, January 10th. Morgan Stanley started coverage on Hims & Hers Health in a report on Tuesday, December 17th. They issued an “overweight” rating and a $42.00 price objective for the company. Bank of America cut Hims & Hers Health from a “buy” rating to an “underperform” rating and dropped their price objective for the company from $32.00 to $18.00 in a report on Thursday, November 14th. Deutsche Bank Aktiengesellschaft lifted their price objective on Hims & Hers Health from $23.00 to $27.00 and gave the company a “hold” rating in a report on Wednesday, November 6th. Finally, Piper Sandler lifted their price objective on Hims & Hers Health from $21.00 to $24.00 and gave the company a “neutral” rating in a report on Monday, January 6th. Two investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and an average price target of $25.13.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of HIMS. Vanguard Group Inc. lifted its stake in shares of Hims & Hers Health by 11.1% in the 4th quarter. Vanguard Group Inc. now owns 20,257,116 shares of the company’s stock valued at $489,817,000 after acquiring an additional 2,020,722 shares during the last quarter. Yong Rong HK Asset Management Ltd bought a new position in shares of Hims & Hers Health in the 4th quarter valued at $41,104,000. Principal Financial Group Inc. lifted its stake in shares of Hims & Hers Health by 370.3% in the 4th quarter. Principal Financial Group Inc. now owns 1,365,769 shares of the company’s stock valued at $33,024,000 after acquiring an additional 1,075,355 shares during the last quarter. Wellington Management Group LLP raised its position in Hims & Hers Health by 34.5% during the 3rd quarter. Wellington Management Group LLP now owns 3,444,414 shares of the company’s stock worth $63,446,000 after purchasing an additional 883,230 shares during the last quarter. Finally, Raymond James Financial Inc. bought a new position in Hims & Hers Health during the 4th quarter worth $18,048,000. 63.52% of the stock is currently owned by institutional investors.

Hims & Hers Health Company Profile

Hims & Hers Health, Inc operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.